Molina, J. R., Ward, J., Hecht, J. R., Kirtane, K., Marar, R., Fankuchen, O. R., Mitchell, J., Maloney, D. G., Maus, M. V., Eng, C., Hazim, A. Z., Patel, S. P., Dorigo, O., He, K., Lou, Y., Kundranda, M. N., Vu, P., Xuan, J. D., Avila, M., Punekar, S. R. (2026). Initial safety and efficacy of A2B694, a logic-gated mesothelin (MSLN)–targeted Tmod chimeric antigen receptor T-cell (CAR T) therapy in patients with advanced solid tumors with HLA-A*02 loss of heterozygosity (LOH).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8579